We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vagotomy Could Encourage Weight Loss

By HospiMedica staff writers
Posted on 18 Jul 2007
Cutting the vagus nerve could be a possible, less aggressive alternative for people afraid of bariatric surgery, or those not quite obese enough to qualify for it, recommends a new study.

Researchers at the University of California San Francisco (UCSF, USA) and the University of Rochester (NY, USA) examined the utility of laparoscopic truncal vagotomy in the treatment of morbid obesity in adults. More...
Vagotomy was performed on 26 female and four male obese patients. The patients had an average body mass index (BMI) score of between 35 and 45.

The study found that 10 of the 11 patients who were one year past surgery responded to the procedure and that they lost an average of 18.4% of their excess body weight. The researchers stated that these results are in line with the results of older, ulcer treatment studies, which found about 20% excess weight loss. The patients suffered no serious side effects and went home hours later with little pain. The results were presented at the 24th annual meeting of the American Society for Bariatric Surgery, held during June 2007 in San Diego (CA, USA).

"By no means do I think this is a panacea,” said lead author Robert Lustig, M.D., a pediatric endocrinologist at UCSF. "But I think this will be a rational alternative for a cadre of patients that are sort of in the middle there. With as much obesity as we have in this country, that's a big middle.”

Vagotomy is the surgical division of fibers of the vagus nerve, usually used to diminish acid secretion of the stomach and control a duodenal ulcer. The frequency with which elective vagotomy is performed has decreased in the past 20 years as drugs have become increasingly effective in treating ulcers.


Related Links:
University of California San Francisco
University of Rochester

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.